Downregulation of glial scarring after brain injury: The effect of purine nucleoside analogue ribavirin

Annals of the New York Academy of Sciences

Volumn 1048, Issue , 2005, Pages 296-310

  Peković, Sanja ^a   Filipović, Radmila ^b   Šubašić, Sanja ^a   Lavrnja, Irena ^a   Stojkov, Danijela ^a   Nedeljković, Nadežda ^a   Rakić, Ljubisav ^a   Stojiljković, Mirjana ^a  

^a UNIVERSITY OF BELGRADE   (Serbia)

^b UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

Author keywords

Brain injury; Glial scar; Reactive astrocytes; Ribavirin

Indexed keywords

GLIAL FIBRILLARY ACIDIC PROTEIN; PURINE NUCLEOSIDE DERIVATIVE; RIBAVIRIN; VIMENTIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ASTROCYTOSIS; BRAIN INJURY; CONFERENCE PAPER; CONTROLLED STUDY; DRUG MECHANISM; FEMALE; GLIA CELL; IMMUNOCYTOCHEMISTRY; MALE; NONHUMAN; PROTEIN EXPRESSION; RAT; SENSORIMOTOR CORTEX;

EID: 25144478862     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1196/annals.1342.027     Document Type: Conference Paper

References (68)

1. MILLER, D.J. 1993. Head injury. J. Neurol. Neurosurg. Psychiatry. 56: 440-447.
2. MORRISON, B. III et al. 1998. In vitro central nervous system models of mechanically induced trauma: a review. J. Neurotrauma 11: 911-928.
3. BULLOCK, M.R., E.G. LYETH & J.P. MUIZELAAR. 1999. Current status of neuroprotection trials for traumatic brain injury: lessons from animal models and clinical studies. Neurosurgery 45: 207-220.
4. REIER, P.J., L.J. STENSAAS & L. GUTH. 1983. The astrocytic scar as an impediment to regeneration in the central nervous system. In Spinal Cord Reconstruction. C.C. Kao et al., Eds.: 163-195. Raven Press. New York.
5. FITCH, M.T. et al. 1999. Cellular and molecular mechanisms of glial scarring and progressive cavitation: in vivo and in vitro analysis of inflammation-induced secondary injury after CNS trauma. J. Neurosci. 19: 8182-8198.
6. SILVER, J. & J.H. MILLER. 2004. Regeneration beyond the glial scar. Nature 5: 146-156.
7. FITCH, M.T. & J. SILVER. 1997. Activated macrophages and the blood-brain barrier: inflammation after CNS injury leads to increases in putative inhibitory molecules. Exp. Neurol. 2: 587-603.
8. RIDET, J.L. et al. 1997. Reactive astrocytes: cellular and molecular cues to biological function. Trends Neurosci. 20: 570-577.
9. HOWES, E.A. & P.J.S. SMITH. 2002. Glial cell involvement in brain repair and the effects of aging. In Neuroglia in the Aging Brain. J.S. de Vellis, Ed.: 113-134. Humana Press Inc. Totowa, NJ.
10. SCHWARTZ, J.P. & N. NISHIYAMA. 1994. Neurotrophic factor gene expression in astrocytes during development and following injury. Brain Res. Bull. 35: 403-407.
11. FRAUTSCHY, S.A., P.A. WALICKE & A. BAIRD. 1991. Localization of basic fibroblast growth factor and its mRNA after CNS injury. Brain Res. 553: 291-299.
12. LOGAN, A. & M. BERRY. 1993. Transforming growth factor-beta 1 and basic fibroblast growth factor in the injured CNS. Trends Pharmacol. Sci. 14: 337-342.
13. SMITH, G.M. & R.H. MILLER. 1996. Immature type-1 astrocytes suppress glial formation, are motile and interact with blood vessels. Brain Res. 543: 112-122.
14. FAWCETT, J.W. & R.A. ASHER. 1999. The glial scar and central nervous system repair. Brain Res. Bull. 49: 377-391.
15. MCGRAW, J., G.W. HIEBERT & J.D. STEEVES. 2001. Modulating astrogliosis after neurotrauma. J. Neurosci. Res. 63: 109-115.
16. SIDWELL, R.W. et al. 1972. Broad-spectrum antiviral activity of Virazole: 1-beta-D-ribofuranosyl-1,2,4-triazole-3-carboxamide. Science 177: 705-706.
17. WITKOWSKI, J.T. et al. 1972. Design, synthesis, and broad spectrum antiviral activity of 1-β-D-ribofuranosyl-1,2,4-triazole-3 carboxamide and related nucleosides. J. Med. Chem. 15: 1150-1154.
18. TAM, R.C., I.Y.N. LAU & Z. HONG. 2001. Mechanisms of action of ribavirin in antiviral therapies. Antiviral Chem. Chemother 12: 267-278.
19. SIDWELL, R.W., R.K. ROBINS & I.W. HILLYARD. 1979. Ribavirin: an antiviral agent. Pharmacol. Ther. 6: 123-146.
20. WINGARD, J.R. et al. 1983. Effect of several antiviral agents on human lymphocyte functions and marrow progenitor cell proliferation. Antimicrob. Agents Chemother. 23: 593-597.
21. WYDE, P.R. 1998. Respiratory syncytial virus (RSV) disease and prospects for its control. Antiviral Res. 39: 63-79.
22. FERNANDEZ-LARSSON, R. & J.L. PATTERSON. 1990. Ribavirin is an inhibitor of human immunodeficiency virus reverse transcriptase. Mol. Pharmacol. 38: 766-770.
23. PEAVY, D.L., C.N. POWERS & V. KNIGHT. 1981. Inhibition of murine plaque-forming cell responses in vivo by ribavirin. J. Immunol. 126: 861-864.
24. FRANCHETTI, P. & M. GRIFANTINI. 1999. Nucleoside and non-nucleoside IMP dehydrogenase inhibitors as antitumor and antiviral agents. Curr. Med. Chem. 6: 599-614.
25. MILICEVIC, I. et al. 2003. Ribavirin reduces clinical signs and pathological changes of experimental autoimmune encephalomyelitis in dark agouti rats. J. Neurosci. Res. 72: 268-278.
26. PEAVY, D.L. et al. 1980. Inhibition of lymphocyte proliferative responses by ribavirin. Infect. Immun. 29: 583-589.
27. BOYA, J., J.L. CALVO, A. LÓPEZ-CARBONELL & J.E. GARCÍA-MAURIÑO. 2002. Astrocytic reaction after traumatic brain injury. In Neuroglia in the Aging Brain. J.S. de Vellis, Ed.: 35-56. Humana Press Inc. Totowa, NJ.
28. SHERWOOD, N.M. & P.S. TIMIRAS. 1970. A stereotaxic atlas of the developing rat brain. University of California Press. Berkeley, CA.
29. PAXINOS, G. & C. WATSON. 1982. The rat brain in stereotaxic coordinates. Academic Press. New York.
30. STOJILJKOVIC, M., S. PEKOVIC & L. RAKIC. 1998. Changes of glycosaminoglycans after unilateral sensorimotor cortex ablation in neonatal rats. Arch. Biol. Sci. 50: 219-226.
31. AMAT, J. A. et al. 1996. Phenotype diversity and kinetics of proliferating microglia and astrocytes following cortical stab injury. Glia 16: 368-382.
32. FREDERICKSON, R.C. & J. SILVER. 1991. Glial cells: The Unsung heroes of the brain. One company's view. Bio/Technology 9: 1042-1049.
33. BIGNAMI, A. & D. DAHL. 1976. The astroglial response to stabbing: immunofluorescence studies with antibodies to astrocyte- specific protein (GFA) in mammalian and submammalian vertebrates. Neuropathol. Appl. Neurobiol. 2: 99-110.
34. FINLAY, B.L., A.T. BERRY & D.R. SENGELAUB. 1982. Cell death in the mammalian visual system during normal development: II superior collicus. J. Comp. Neurol. 204: 318-324.
35. OBLINGER, M.M. & L.D. SINGH. 1993. Reactive astrocytes in neonate brain upregulate intermediate filament gene expression in response to axonal injury. Int. J. Dev. Neurosci. 11: 149-156.
36. KALMAN, M., B.M. AJTAI, & J.H. SOMMERNES. 2000. Characteristics of glial reaction in the perinatal rat cortex: effect of lesion size in the critical period. Neural Plast. 7: 147-165
37. KOLB, B., B. PETRIE & J. CIOE. 1996. Recovery from early cortical damage in rats, VII. Comparison of the behavioural and anatomical effects of medial prefrontal lesions at different ages of neural maturation. Behav. Brain Res. 79: 1-13.
38. SCHWAB, M.E. & D. BERTHOLDI. 1996. Degeneration and regeneration of axons in the lesioned spinal cord. Physiol. Rev. 76: 319-370.
39. HOZUMI, I., D.A. AQUINO & W.T. NORTON. 1990. GFAP mRNA levels following stab wounds in rat brain. Brain Res. 534: 291-294.
40. NORTON, W.T. et al. 1992. Quantitative aspects of reactive gliosis: a review. Neurochem. Res. 17: 877-885.
41. POLTORAK, M. et al. 1993. Effects of frontal cortical lesions on mouse striatum: reorganization of cell recognition molecule, glial fiber, and synaptic protein expression in the dorsomedial striatum. J. Neurosci. 13: 2217-2229.
42. ROITBAK, T. & E. SYKOVA. 1999. Diffusion barriers evoked in the rat cortex by reactive astrogliosis. Glia 28: 40-48.
43. MALHOTRA, S.K. & T.K. SHNITKA. 2002. Diversity in reactive astrocytes. In Neuroglia in the Aging Brain. J.S. de Vellis, Ed.: 17-33. Humana Press Inc. Totowa, NJ
44. MATHEWSON, A.J. & M. BERRY. 1985. Observations on the astrocyte response to cerebral stab wound in adult rats. Brain Res. 327: 61-69.
45. BALASINGAM, V. et al. 1994. Reactive astrogliosis in the neonatal mouse brain and its modulation by cytokines. J. Neurosci. 14: 846-865.
46. SCHIFFER, D. et al. 1993. Immunohistochemistry of glial reaction after injury in the rat: Double stainings and markers of cell proliferation. Int. J. Dev. Neurosci. 11: 269-280.
47. DAHL, D. et al. 1981. Vimentin, the 57,000 molecular weight protein in fibroblast filaments in the major cytoskeletal protein in immature glia. Eur. J. Cell Biol. 24: 191-196.
48. GREGG, C.T., A.K. CHOJNACKI & S. WEISS. 2002. Radial glial cells as neuronal precursors: the next generation? J. Neurosci. Res. 69: 708-713.
49. ROSEN, G.D., G.F. SHERMAN & A.M. GALABURDA. 1994. Radial glia in the neocortex of adult rats: effects of neonatal brain injury. Brain Res. Dev. Brain Res. 82: 127-135.
50. NORRIS, C.R. & K. KALIL. 1991. Guidance of callosal axons by radial glia in the developing cerebral cortex. J. Neurosci. 11: 3481-3492.
51. ROSEN, G.D. et al. 1992. The development of induced cerebrocortical microgyria in the rat. J. Neuropathol. Exp. Neurol. 51: 601-611.
52. AJTAI, B.M. & M. KALMAN. 2001. Reactive glia support and guide axon growth in the rat thalamus during the first postnatal week. A sharply timed transition from permissive to non-permissive stage. Int. J. Dev. Neurosci. 19: 589-597.
53. YU, A.C., Y.L. LEE & L.F. ENG. 1993. Astrogliosis in culture: I. The model and the effect of antisense oligonucleotides on glial fibrillary acidic protein synthesis. J. Neurosci. Res. 34: 295-303.
54. MOON, L.D., R.A. ASHER & J.W. FAWCETT. 2003. Limited growth of severed CNS axons after treatment of adult rat brain with hyaluronidase. J. Neurosci. Res. 71: 23-37.
55. PATTERSON, J.L. & R. FERNANDEZ-LARSSON. 1990. Molecular mechanisms of action of ribavirin. Rev. Infect. Dis. 12: 1139-1146.
56. CROTTY, S., C. CAMERON & R. ANDINO. 2002. Ribavirin's antiviral mechanism of action: lethal mutagenesis? J. Mol. Med. 80: 86-95.
57. HONG, Z. & C.E. CAMERON. 2002. Pleiotropic mechanisms of ribavirin antiviral activities. Prog. Drug Res. 59: 41-69.
58. LI, W., F. SHEN & G. WEBER. 1999. Ribavirin and quercetin synergistically downregulate signal transduction and are cytotoxic in human ovarian carcinoma cells. Oncol. Res. 11: 243-247.
59. 1. Eur. J. Pharmacology 404: 46-62.
60. BJELOBABA I. et al. 2004. Downregulation of ERK-MAP signaling pathway by ribavirin after stub wound of rat sensorimotor cortex. 22nd International Symposium on Biophysics, Sv. Stefan/Belgrade, Serbia and Montenegro. Book of Abstracts W1: P4.
61. ILYIN, G.P. et al. 1998. Ribavirin inhibits protein synthesis and cell proliferation induced by mitogenic factors in primary human and rat hepatocytes. Hepatology 27: 1687-1694.
62. MAJUMDAR, A. et al. 1995. IL-3 and ribavirin induce differentiation and growth suppression during long-term treatment of a megakaryocytic leukemia cell line. J. Cell Physiol. 165: 530-537.
63. SOLBRIG, M.V. et al. 2002. Neuroprotection and reduced proliferation of microglia in ribavirin-treated bornavirus-infected rats. Antimicrob. Agents Chemother. 46: 2287-2291.
64. STOJILJKOVIC, M. et al. 2004. Ribavirin suppresses reactive gliosis after brain injury in adults. Program No. 230.5, Abstract Viewer/Itinerary Planner. Society for Neuroscience. 34th Annual meeting. San Diego, CA.
65. SUBASIC, S. et al. 2004. Ribavirin down-regulates proliferation of oligodendrocyte precursor cells and thereby suppresses glial scarring after brain injury in adults. 22nd International Symposium on Biophysics, Sv. Stefan/Belgrade, Serbia and Montenegro. Book of Abstracts W1: P5.
66. MILENKOVIC, I. et al. 2005. Pattern of glial fibrillary acidic protein expression following kainate-induced cerebellar lesion in rats. Neurochemical Res. 30: 207-213.
67. DI PROSPERO, N.A. et al. 1998. Suramin disrupts the gliotic response following a stab wound injury to the adult rat brain. J. Neurocytol. 27: 491-506.
68. HARVIE, P. et al. 1996. Antiviral efficacy and toxicity of ribavirin in murine acquired immunodeficiency syndrome model. J. Acquir. Immune. Defic. Syndr. Hum. Retrovirol. 12: 451-461.